Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1729 entries
Sorted by: Best Match Show Resources per page
Preparation and Distribution of Cannabis and Cannabis-Derived Dosage Formulations for Investigational and Therapeutic Use in the United States.

Frontiers in pharmacology

Thomas BF, Pollard GT.
PMID: 27630566
Front Pharmacol. 2016 Aug 31;7:285. doi: 10.3389/fphar.2016.00285. eCollection 2016.

Cannabis is classified as a schedule I controlled substance by the US Drug Enforcement Agency, meaning that it has no medicinal value. Production is legally restricted to a single supplier at the University of Mississippi, and distribution to researchers...

Cite
Thomas BF, Pollard GT. Preparation and Distribution of Cannabis and Cannabis-Derived Dosage Formulations for Investigational and Therapeutic Use in the United States. Front Pharmacol. 2016;7:285doi: 10.3389/fphar.2016.00285.
Thomas, B. F., & Pollard, G. T. (2016). Preparation and Distribution of Cannabis and Cannabis-Derived Dosage Formulations for Investigational and Therapeutic Use in the United States. Frontiers in pharmacology, 7285. https://doi.org/10.3389/fphar.2016.00285
Thomas, Brian F, and Pollard, Gerald T. "Preparation and Distribution of Cannabis and Cannabis-Derived Dosage Formulations for Investigational and Therapeutic Use in the United States." Frontiers in pharmacology vol. 7 (2016): 285. doi: https://doi.org/10.3389/fphar.2016.00285
Thomas BF, Pollard GT. Preparation and Distribution of Cannabis and Cannabis-Derived Dosage Formulations for Investigational and Therapeutic Use in the United States. Front Pharmacol. 2016 Aug 31;7:285. doi: 10.3389/fphar.2016.00285. eCollection 2016. PMID: 27630566; PMCID: PMC5006560.
Copy Download .nbib Format: NLM
Is the medical use of cannabis a therapeutic option for children?.

Paediatrics & child health

Rieder MJ.
PMID: 26941559
Paediatr Child Health. 2016 Jan-Feb;21(1):31-4. doi: 10.1093/pch/21.1.31.

Cannabis is a psychoactive compound with a long history of recreational and therapeutic use. Current considerations regarding cannabis use for medical purposes in children have been stimulated by recent case reports describing its beneficial effect with refractory epilepsy. Overall,...

Cite
Rieder MJ. Is the medical use of cannabis a therapeutic option for children?. Paediatr Child Health. 2016;21(1):31-4doi: 10.1093/pch/21.1.31.
Rieder, M. J. (2016). Is the medical use of cannabis a therapeutic option for children?. Paediatrics & child health, 21(1), 31-4. https://doi.org/10.1093/pch/21.1.31
Rieder, Michael J. "Is the medical use of cannabis a therapeutic option for children?." Paediatrics & child health vol. 21,1 (2016): 31-4. doi: https://doi.org/10.1093/pch/21.1.31
Rieder MJ. Is the medical use of cannabis a therapeutic option for children?. Paediatr Child Health. 2016 Jan-Feb;21(1):31-4. doi: 10.1093/pch/21.1.31. PMID: 26941559; PMCID: PMC4758425.
Copy Download .nbib Format: NLM
Even High Doses of Oral Cannabidol Do Not Cause THC-Like Effects in Humans: Comment on Merrick et al. .

Cannabis and cannabinoid research

Grotenhermen F, Russo E, Zuardi AW.
PMID: 28861499
Cannabis Cannabinoid Res. 2017 Jan 01;2(1):1-4. doi: 10.1089/can.2016.0036. eCollection 2017.

This short communication examines the question whether the experimental data presented in a study by Merrick et al. are of clinical relevance. These authors found that cannabidiol (CBD), a major cannabinoid of the cannabis plant devoid of psychotropic effects...

Cite
Grotenhermen F, Russo E, Zuardi AW. Even High Doses of Oral Cannabidol Do Not Cause THC-Like Effects in Humans: Comment on Merrick et al. . Cannabis Cannabinoid Res. 2017;2(1):1-4doi: 10.1089/can.2016.0036.
Grotenhermen, F., Russo, E., & Zuardi, A. W. (2017). Even High Doses of Oral Cannabidol Do Not Cause THC-Like Effects in Humans: Comment on Merrick et al. . Cannabis and cannabinoid research, 2(1), 1-4. https://doi.org/10.1089/can.2016.0036
Grotenhermen, Franjo, et al. "Even High Doses of Oral Cannabidol Do Not Cause THC-Like Effects in Humans: Comment on Merrick et al. ." Cannabis and cannabinoid research vol. 2,1 (2017): 1-4. doi: https://doi.org/10.1089/can.2016.0036
Grotenhermen F, Russo E, Zuardi AW. Even High Doses of Oral Cannabidol Do Not Cause THC-Like Effects in Humans: Comment on Merrick et al. . Cannabis Cannabinoid Res. 2017 Jan 01;2(1):1-4. doi: 10.1089/can.2016.0036. eCollection 2017. PMID: 28861499; PMCID: PMC5531368.
Copy Download .nbib Format: NLM
Data on individual metabolites of synthetic cannabinoids JWH-018, JWH-073 and AM2201 by Cunninghamella elegans.

Data in brief

Watanabe S, Kuzhiumparambil U, Winiarski Z, Fu S.
PMID: 26977432
Data Brief. 2016 Feb 23;7:332-40. doi: 10.1016/j.dib.2016.02.039. eCollection 2016 Jun.

Synthetic cannabinoids JWH-018, JWH-073 and AM2201 were metabolised by the fungus Cunninghamella elegans. In this article, data on individual metabolites of their retention times, mass accuracies, major product ions and structures indicated by product ions are presented. The data...

Cite
Watanabe S, Kuzhiumparambil U, Winiarski Z, et al. Data on individual metabolites of synthetic cannabinoids JWH-018, JWH-073 and AM2201 by Cunninghamella elegans. Data Brief. 2016;7:332-40doi: 10.1016/j.dib.2016.02.039.
Watanabe, S., Kuzhiumparambil, U., Winiarski, Z., & Fu, S. (2016). Data on individual metabolites of synthetic cannabinoids JWH-018, JWH-073 and AM2201 by Cunninghamella elegans. Data in brief, 7332-40. https://doi.org/10.1016/j.dib.2016.02.039
Watanabe, Shimpei, et al. "Data on individual metabolites of synthetic cannabinoids JWH-018, JWH-073 and AM2201 by Cunninghamella elegans." Data in brief vol. 7 (2016): 332-40. doi: https://doi.org/10.1016/j.dib.2016.02.039
Watanabe S, Kuzhiumparambil U, Winiarski Z, Fu S. Data on individual metabolites of synthetic cannabinoids JWH-018, JWH-073 and AM2201 by Cunninghamella elegans. Data Brief. 2016 Feb 23;7:332-40. doi: 10.1016/j.dib.2016.02.039. eCollection 2016 Jun. PMID: 26977432; PMCID: PMC4781962.
Copy Download .nbib Format: NLM
Synthetic Cannabinoid Induced acute Tubulointerstitial Nephritis and Uveitis Syndrome: A Case Report and Review of Literature.

Journal of clinical and diagnostic research : JCDR

Sinangil A, Celik V, Kockar A, Ecder T.
PMID: 27437289
J Clin Diagn Res. 2016 May;10(5):OD31-2. doi: 10.7860/JCDR/2016/18762.7826. Epub 2016 May 01.

Tubulointerstitial Nephritis with Uveitis (TINU) syndrome is a rarely seen syndrome. The interstitial nephritis may be with the concurrent uveitis and can also develop before or after uveitis. The syndrome can resolve after elimination of the culprit destructive factors,...

Cite
Sinangil A, Celik V, Kockar A, et al. Synthetic Cannabinoid Induced acute Tubulointerstitial Nephritis and Uveitis Syndrome: A Case Report and Review of Literature. J Clin Diagn Res. 2016;10(5):OD31-2doi: 10.7860/JCDR/2016/18762.7826.
Sinangil, A., Celik, V., Kockar, A., & Ecder, T. (2016). Synthetic Cannabinoid Induced acute Tubulointerstitial Nephritis and Uveitis Syndrome: A Case Report and Review of Literature. Journal of clinical and diagnostic research : JCDR, 10(5), OD31-2. https://doi.org/10.7860/JCDR/2016/18762.7826
Sinangil, Ayse, et al. "Synthetic Cannabinoid Induced acute Tubulointerstitial Nephritis and Uveitis Syndrome: A Case Report and Review of Literature." Journal of clinical and diagnostic research : JCDR vol. 10,5 (2016): OD31-2. doi: https://doi.org/10.7860/JCDR/2016/18762.7826
Sinangil A, Celik V, Kockar A, Ecder T. Synthetic Cannabinoid Induced acute Tubulointerstitial Nephritis and Uveitis Syndrome: A Case Report and Review of Literature. J Clin Diagn Res. 2016 May;10(5):OD31-2. doi: 10.7860/JCDR/2016/18762.7826. Epub 2016 May 01. PMID: 27437289; PMCID: PMC4948465.
Copy Download .nbib Format: NLM
The emerging threat of synthetic cannabinoids.

Nursing management

[No authors listed]
PMID: 28234757
Nurs Manage. 2017 Mar;48(3):1. doi: 10.1097/01.NUMA.0000513501.37962.5c.

No abstract available.

Cite
The emerging threat of synthetic cannabinoids. Nurs Manage. 2017;48(3):1doi: 10.1097/01.NUMA.0000513501.37962.5c.
(2017). The emerging threat of synthetic cannabinoids. Nursing management, 48(3), 1. https://doi.org/10.1097/01.NUMA.0000513501.37962.5c
"The emerging threat of synthetic cannabinoids." Nursing management vol. 48,3 (2017): 1. doi: https://doi.org/10.1097/01.NUMA.0000513501.37962.5c
The emerging threat of synthetic cannabinoids. Nurs Manage. 2017 Mar;48(3):1. doi: 10.1097/01.NUMA.0000513501.37962.5c. PMID: 28234757.
Copy Download .nbib Format: NLM
Rising Threat; Bonsai.

Turkish journal of emergency medicine

Aksel G, Bozan O, Kayaci M, Guneysel O, Sezgin SB.
PMID: 27336068
Turk J Emerg Med. 2016 Mar 02;15(2):75-8. doi: 10.5505/1304.7361.2015.80388. eCollection 2015 Jun.

OBJECTIVES: In recent years, and especially in the past few months, the number of synthetic cannabinoid (bonsai) users has increased in our country. The aim of this study was to draw attention to the consumption of bonsai among young...

Cite
Aksel G, Bozan O, Kayaci M, et al. Rising Threat; Bonsai. Turk J Emerg Med. 2016;15(2):75-8doi: 10.5505/1304.7361.2015.80388.
Aksel, G., Bozan, O., Kayaci, M., Guneysel, O., & Sezgin, S. B. (2015). Rising Threat; Bonsai. Turkish journal of emergency medicine, 15(2), 75-8. https://doi.org/10.5505/1304.7361.2015.80388
Aksel, Gokhan, et al. "Rising Threat; Bonsai." Turkish journal of emergency medicine vol. 15,2 (2015): 75-8. doi: https://doi.org/10.5505/1304.7361.2015.80388
Aksel G, Bozan O, Kayaci M, Guneysel O, Sezgin SB. Rising Threat; Bonsai. Turk J Emerg Med. 2016 Mar 02;15(2):75-8. doi: 10.5505/1304.7361.2015.80388. eCollection 2015 Jun. PMID: 27336068; PMCID: PMC4910010.
Copy Download .nbib Format: NLM
Legal highs: staying on top of the flood of novel psychoactive substances.

Therapeutic advances in psychopharmacology

Baumeister D, Tojo LM, Tracy DK.
PMID: 26240749
Ther Adv Psychopharmacol. 2015 Apr;5(2):97-132. doi: 10.1177/2045125314559539.

There has been growing clinical, public, and media awareness and concern about the availability and potential harmfulness of so-called 'legal highs', which are more appropriately called new or novel psychoactive substances (NPS). A cat-and-mouse process has emerged wherein unknown...

Cite
Baumeister D, Tojo LM, Tracy DK. Legal highs: staying on top of the flood of novel psychoactive substances. Ther Adv Psychopharmacol. 2015;5(2):97-132doi: 10.1177/2045125314559539.
Baumeister, D., Tojo, L. M., & Tracy, D. K. (2015). Legal highs: staying on top of the flood of novel psychoactive substances. Therapeutic advances in psychopharmacology, 5(2), 97-132. https://doi.org/10.1177/2045125314559539
Baumeister, David, et al. "Legal highs: staying on top of the flood of novel psychoactive substances." Therapeutic advances in psychopharmacology vol. 5,2 (2015): 97-132. doi: https://doi.org/10.1177/2045125314559539
Baumeister D, Tojo LM, Tracy DK. Legal highs: staying on top of the flood of novel psychoactive substances. Ther Adv Psychopharmacol. 2015 Apr;5(2):97-132. doi: 10.1177/2045125314559539. PMID: 26240749; PMCID: PMC4521440.
Copy Download .nbib Format: NLM
Cannabis sativa: The Plant of the Thousand and One Molecules.

Frontiers in plant science

Andre CM, Hausman JF, Guerriero G.
PMID: 26870049
Front Plant Sci. 2016 Feb 04;7:19. doi: 10.3389/fpls.2016.00019. eCollection 2016.

Cannabis sativa L. is an important herbaceous species originating from Central Asia, which has been used in folk medicine and as a source of textile fiber since the dawn of times. This fast-growing plant has recently seen a resurgence...

Cite
Andre CM, Hausman JF, Guerriero G. Cannabis sativa: The Plant of the Thousand and One Molecules. Front Plant Sci. 2016;7:19doi: 10.3389/fpls.2016.00019.
Andre, C. M., Hausman, J. F., & Guerriero, G. (2016). Cannabis sativa: The Plant of the Thousand and One Molecules. Frontiers in plant science, 719. https://doi.org/10.3389/fpls.2016.00019
Andre, Christelle M, et al. "Cannabis sativa: The Plant of the Thousand and One Molecules." Frontiers in plant science vol. 7 (2016): 19. doi: https://doi.org/10.3389/fpls.2016.00019
Andre CM, Hausman JF, Guerriero G. Cannabis sativa: The Plant of the Thousand and One Molecules. Front Plant Sci. 2016 Feb 04;7:19. doi: 10.3389/fpls.2016.00019. eCollection 2016. PMID: 26870049; PMCID: PMC4740396.
Copy Download .nbib Format: NLM
Plant derived substances with anti-cancer activity: from folklore to practice.

Frontiers in plant science

Fridlender M, Kapulnik Y, Koltai H.
PMID: 26483815
Front Plant Sci. 2015 Oct 01;6:799. doi: 10.3389/fpls.2015.00799. eCollection 2015.

Plants have had an essential role in the folklore of ancient cultures. In addition to the use as food and spices, plants have also been utilized as medicines for over 5000 years. It is estimated that 70-95% of the...

Cite
Fridlender M, Kapulnik Y, Koltai H. Plant derived substances with anti-cancer activity: from folklore to practice. Front Plant Sci. 2015;6:799doi: 10.3389/fpls.2015.00799.
Fridlender, M., Kapulnik, Y., & Koltai, H. (2015). Plant derived substances with anti-cancer activity: from folklore to practice. Frontiers in plant science, 6799. https://doi.org/10.3389/fpls.2015.00799
Fridlender, Marcelo, et al. "Plant derived substances with anti-cancer activity: from folklore to practice." Frontiers in plant science vol. 6 (2015): 799. doi: https://doi.org/10.3389/fpls.2015.00799
Fridlender M, Kapulnik Y, Koltai H. Plant derived substances with anti-cancer activity: from folklore to practice. Front Plant Sci. 2015 Oct 01;6:799. doi: 10.3389/fpls.2015.00799. eCollection 2015. PMID: 26483815; PMCID: PMC4589652.
Copy Download .nbib Format: NLM
In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma.

Current oncology (Toronto, Ont.)

Fisher T, Golan H, Schiby G, PriChen S, Smoum R, Moshe I, Peshes-Yaloz N, Castiel A, Waldman D, Gallily R, Mechoulam R, Toren A.
PMID: 27022310
Curr Oncol. 2016 Mar;23(2):S15-22. doi: 10.3747/co.23.2893. Epub 2016 Mar 16.

BACKGROUND: Neuroblastoma (nbl) is one of the most common solid cancers in children. Prognosis in advanced nbl is still poor despite aggressive multimodality therapy. Furthermore, survivors experience severe long-term multi-organ sequelae. Hence, the identification of new therapeutic strategies is...

Cite
Fisher T, Golan H, Schiby G, et al. In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma. Curr Oncol. 2016;23(2):S15-22doi: 10.3747/co.23.2893.
Fisher, T., Golan, H., Schiby, G., PriChen, S., Smoum, R., Moshe, I., Peshes-Yaloz, N., Castiel, A., Waldman, D., Gallily, R., Mechoulam, R., & Toren, A. (2016). In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma. Current oncology (Toronto, Ont.), 23(2), S15-22. https://doi.org/10.3747/co.23.2893
Fisher, T, et al. "In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma." Current oncology (Toronto, Ont.) vol. 23,2 (2016): S15-22. doi: https://doi.org/10.3747/co.23.2893
Fisher T, Golan H, Schiby G, PriChen S, Smoum R, Moshe I, Peshes-Yaloz N, Castiel A, Waldman D, Gallily R, Mechoulam R, Toren A. In vitro and in vivo efficacy of non-psychoactive cannabidiol in neuroblastoma. Curr Oncol. 2016 Mar;23(2):S15-22. doi: 10.3747/co.23.2893. Epub 2016 Mar 16. PMID: 27022310; PMCID: PMC4791143.
Copy Download .nbib Format: NLM
Cannabinoid Receptors Modulate Neuronal Morphology and AnkyrinG Density at the Axon Initial Segment.

Frontiers in cellular neuroscience

Tapia M, Dominguez A, Zhang W, Del Puerto A, Ciorraga M, Benitez MJ, Guaza C, Garrido JJ.
PMID: 28179879
Front Cell Neurosci. 2017 Jan 25;11:5. doi: 10.3389/fncel.2017.00005. eCollection 2017.

Neuronal polarization underlies the ability of neurons to integrate and transmit information. This process begins early in development with axon outgrowth, followed by dendritic growth and subsequent maturation. In between these two steps, the axon initial segment (AIS), a...

Cite
Tapia M, Dominguez A, Zhang W, et al. Cannabinoid Receptors Modulate Neuronal Morphology and AnkyrinG Density at the Axon Initial Segment. Front Cell Neurosci. 2017;11:5doi: 10.3389/fncel.2017.00005.
Tapia, M., Dominguez, A., Zhang, W., Del Puerto, A., Ciorraga, M., Benitez, M. J., Guaza, C., & Garrido, J. J. (2017). Cannabinoid Receptors Modulate Neuronal Morphology and AnkyrinG Density at the Axon Initial Segment. Frontiers in cellular neuroscience, 115. https://doi.org/10.3389/fncel.2017.00005
Tapia, Mónica, et al. "Cannabinoid Receptors Modulate Neuronal Morphology and AnkyrinG Density at the Axon Initial Segment." Frontiers in cellular neuroscience vol. 11 (2017): 5. doi: https://doi.org/10.3389/fncel.2017.00005
Tapia M, Dominguez A, Zhang W, Del Puerto A, Ciorraga M, Benitez MJ, Guaza C, Garrido JJ. Cannabinoid Receptors Modulate Neuronal Morphology and AnkyrinG Density at the Axon Initial Segment. Front Cell Neurosci. 2017 Jan 25;11:5. doi: 10.3389/fncel.2017.00005. eCollection 2017. PMID: 28179879; PMCID: PMC5263140.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1729 entries